While Alnylam’s recent reduced revenue guidance spooked investors, analysts remain broadly bullish on the biotech’s ...

Launching on World Heart Day, Retired Professional Football Player Pete Shaw Shares How Symptoms Attributed to Football and Aging Led to a Delayed ATTR-CM Diagnosis – – ‘Play by Play’ Uses Sports to ...

Clinicians should not assume that suspected cardiac amyloidosis in patients with plasma cell dyscrasias is always AL-CM, ...

Jacque Duncan, MD, reviews phase 3 DRAGON data on oral tinlarebant for Stargardt disease and its mechanism-related visual ...

Tara Johnson told Newsweek she wants her daughter to celebrate her entire heritage, including her life before adoption.

Women who had genetic testing for inherited cancer risk years ago may want to ask about testing again, experts say. A ...

Biohackers are embracing Tasso+, a button that draws blood without a needle and measures testosterone, as the market for DIY ...

A new genetic testing regime for children with immune disorders could dramatically cut diagnosis wait times. In-house pathology testing and streamlined access to specialist doctors means children can ...

Women who had genetic testing for inherited cancer risk years ago may want to ask about testing again, experts say.

Is ALNY a good stock to buy? We came across a bullish thesis on Alnylam Pharmaceuticals, Inc. on Astute Optics – US’s ...

Sep. 12 8,260,971 Common Stock of BridgeBio Pharma, Inc. are subject to a Lock-Up Agreement Ending on 13-SEP-2026. CI Sep. 12 133,900 Preferred Stock of BridgeBio Pharma, Inc. are subject to a Lock-Up ...

A study led by scientists at the Holden Arboretum has found evidence that beech leaf disease (BLD) symptom development is genetically controlled, providing the first evidence that some American beech ...